Beyond the Scope Esther Abels | Visiopharm; DPA President-Elect
Esther Abels, co-chair of the DPA Regulatory & Standards Task Force, has worked on the regulatory approval of digital pathology systems since the beginning. She joins Beyond The Scope to discuss her current role advancing the regulatory science of digital pathology and provides an update on the initiatives of the DPA Regulatory and Standards Task Force. Esther also discusses the excitement surrounding digital pathology for precision medicine.
- 2:21 Introduction
- 6:25 Early applications of digital pathology to the pharma industry
- 8:00 Process of validating and achieving FDA approval of the first slide scanners
- 10:00 How collaboration and teamwork help achieve regulatory approval
- 17:48 Current initiatives of the DPA Regulatory and Standars Task Force
- 21:40 510(k) exemption of digital pathology devices
- 25:00 Real world data initiative and is remote sign out permanent?
- 31:08 Using digital pathology for precision medicine
A forum to engage with the hosts and other listeners has been launched on the DPA website www.digitalpathologyassociation.org. DPA members may login to the DPA Collaborate hub (under the Resources tab) and join the Beyond The Scope community. All listeners are encouraged to use this forum to suggest future topics and guests, submit questions and corrections, and provide general feedback.